Jie Wu to Cell Line, Tumor
This is a "connection" page, showing publications Jie Wu has written about Cell Line, Tumor.
Connection Strength
0.324
-
Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. J Biol Chem. 2019 07 05; 294(27):10428-10437.
Score: 0.118
-
Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia. 2018 05; 32(5):1246-1249.
Score: 0.108
-
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. Mol Cancer Ther. 2016 10; 15(10):2521-2529.
Score: 0.098